Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 Doses in the Treatment of Platysma Prominence

NCT05773053 is registered in ClinicalTrials.gov with Merz Aesthetics GmbH as lead sponsor.

NCT NCT05773053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 Doses in the Treatment of Platysma Prominence
Lead sponsor
Merz Aesthetics GmbH
Phase
Phase 2
Overall status
Completed
Start date
March 22, 2023
Completion date
January 24, 2024
Enrollment
73 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

platysma prominence